Matinas BioPharma Hldgs Historical PE Ratio image   This MTNB PE ratio history page last updated 1/13/2025
Matinas BioPharma Hldgs Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2024
11/13/2024
0.71-0.85-3.40NA
Q2 2024
8/14/2024
7.85-1.00-4.00NA
Q1 2024
5/9/2024
8.85-1.50-6.00NA
Q4 2023
3/27/2024
14.50-1.50-6.00NA
Q3 2023
11/8/2023
13.80-1.50-6.00NA
Q2 2023
8/9/2023
16.50-1.50-6.00NA
Q1 2023
5/10/2023
33.50-1.50-6.00NA
Q4 2022
3/15/2023
21.50-1.00-4.00NA
Q3 2022
11/2/2022
39.25-1.50-6.00NA
Q2 2022
8/11/2022
42.35-1.50-6.00NA
Q1 2022
5/12/2022
32.05-1.50-6.00NA
Q4 2021
3/8/2022
29.00-1.50-6.00NA
Q3 2021
11/8/2021
50.50-1.50-6.00NA
Q2 2021
8/10/2021
36.55-1.00-4.00NA
Q1 2021
5/10/2021
38.50-1.50-6.00NA
Q4 2020
3/29/2021
53.00-1.50-6.00NA
Q3 2020
11/6/2020
42.30-1.50-6.00NA
Q2 2020
8/10/2020
46.15-1.50-6.00NA
Q1 2020
5/11/2020
38.20-1.50-6.00NA
Q4 2019
3/9/2020
47.00-2.00-8.00NA
Q3 2019
11/13/2019
45.05-1.50-6.00NA
Q2 2019
8/13/2019
35.60-1.50-6.00NA
Q1 2019
5/14/2019
47.40-2.00-8.00NA
Q4 2018
4/2/2019
53.00-1.50-6.00NA
Q3 2018
11/12/2018
47.80-1.50-6.00NA
Q2 2018
8/10/2018
18.50-2.00-8.00NA
Q1 2018
5/10/2018
26.60-2.50-10.00NA
Q4 2017
3/19/2018
52.00-1.50-6.00NA
Q3 2017
11/15/2017
55.00-2.00-8.00NA
Matinas BioPharma Hldgs PE History Chart
PeriodPriceGAAPTTMPE
Q3 2024
11/13/2024
0.71-0.85-4.85NA
Q2 2024
8/14/2024
7.85-1.00-5.50NA
Q1 2024
5/9/2024
8.85-1.50-6.00NA
Q4 2023
3/27/2024
14.50-1.50-6.00NA
Q3 2023
11/8/2023
13.80-1.50-5.50NA
Q2 2023
8/9/2023
16.50-1.50-5.50NA
Q1 2023
5/10/2023
33.50-1.50-5.50NA
Q4 2022
3/15/2023
21.50-1.00-5.50NA
Q3 2022
11/2/2022
39.25-1.50-4.50NA
Q2 2022
8/11/2022
42.35-1.50-4.50NA
Q1 2022
5/12/2022
32.05-1.50-4.50NA
Q4 2021
3/8/2022
29.00-1.50-5.50NA
Q3 2021
11/8/2021
50.50-1.50-5.50NA
Q2 2021
8/10/2021
36.55-1.00-5.50NA
Q1 2021
5/10/2021
38.50-1.50-6.00NA
Q4 2020
3/29/2021
53.00-1.50-6.00NA
Q3 2020
11/6/2020
42.30-1.50-6.50NA
Q2 2020
8/10/2020
46.15-1.50-6.50NA
Q1 2020
5/11/2020
38.20-1.50-6.50NA
Q4 2019
3/9/2020
47.00-2.00-7.00NA
Q3 2019
11/13/2019
45.05-1.50-6.50NA
Q2 2019
8/13/2019
35.60-1.50-6.50NA
Q1 2019
5/14/2019
47.40-2.00-7.00NA
Q4 2018
4/2/2019
53.00-1.50-7.50NA
Q3 2018
11/12/2018
47.80-1.50-7.50NA
Q2 2018
8/10/2018
18.50-2.00-8.00NA
Q1 2018
5/10/2018
26.60-2.50NANA
Q4 2017
3/19/2018
52.00-1.50NANA
Q3 2017
11/15/2017
55.00-2.00NANA
How should the MTNB historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Matinas BioPharma Hldgs. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this MTNB Historical PE Ratio page.

What is the average historical PE for MTNB based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The MTNB historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for MTNB based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The MTNB historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Matinas BioPharma Hldgs Historical PE Ratio information for Matinas BioPharma Hldgs' stock. The average MTNB historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MTNB historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MTNB historical PE result, against the recent PE: when this page was posted on 1/10/2025, the most recent closing price for MTNB had been 0.62, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on MTNB or any other given stock, valuation analysis for MTNB can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Matinas BioPharma Hldgs PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MTNB. Thanks for visiting, and the next time you need to research MTNB Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ROCH Historical Stock Prices, Top Ten Hedge Funds Holding FPA, GXP Videos.

 

Matinas BioPharma Hldgs Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2025, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.